Filter
3832
Filtered Results: 3832
Text search:
tb
treatment
Featured
Recommendations
322
New Publications
1080
Language
Document type
No document type
2503
Studies & Reports
474
Guidelines
397
Manuals
137
Strategic & Response Plan
107
Fact sheets
67
Situation Updates
62
Training Material
50
Infographics
17
Resource Platforms
9
Online Courses
4
Brochures
3
Videos
2
Countries / Regions
India
203
Kenya
139
South Africa
135
Western and Central Europe
100
Global
94
Uganda
89
Tanzania
87
Ethiopia
83
Zambia
77
Malawi
77
Nepal
76
Nigeria
67
Sierra Leone
65
Eastern Europe
63
Liberia
61
Africa
60
Namibia
56
Rwanda
54
Myanmar / Burma
51
Bangladesh
49
Ghana
48
Lesotho
47
Ukraine
46
Latin America and the Carribbean
41
Cambodia
37
Zimbabwe
35
Philippines
33
Indonesia
31
Asia
30
South–East Asia Region
25
Botswana
24
Mozambique
23
Senegal
22
Germany
21
Russia
20
South Sudan
18
Brazil
18
Congo, Democratic Republic of
16
Eswatini/ Swaziland
15
East and Southern Africa
15
Burkina Faso
14
Syria
14
Argentina
14
Colombia
13
Paraguay
13
Pakistan
12
Guinea
10
Haiti
10
Benin
10
West and Central Africa
10
Middle East and North Africa
10
Venezuela
10
Peru
9
Albania
9
Georgia
8
Cameroon
7
Ecuador
7
Bolivia
7
Armenia
7
Southern Africa
7
Tajikistan
7
Thailand
6
Sudan
6
Madagascar
6
Yemen
6
Afghanistan
5
Angola
5
Western Pacific Region
5
Moldova
5
Vietnam
5
Somalia
4
Jordan
4
Lebanon
4
Papua New Guinea
4
Central African Republic
4
El Salvador
4
Sri Lanka
4
Eastern Europe and Central Asia
4
Laos
4
Timor Leste/ East Timor
4
Iran
4
USA
3
Saudi Arabia
3
Iraq
3
North Macedonia
3
Burundi
3
Chile
3
Bhutan
3
Estonia
3
North America
3
Guinea-Bissau
2
Morocco
2
Chad
2
Poland
2
Romania
2
Belarus
2
Mali
1
Côte d’Ivoire / Ivory Coast
1
Niger
1
Egypt
1
Gambia
1
Ireland
1
Singapore
1
Switzerland
1
Hungary
1
Greece
1
Libya
1
Nicaragua
1
Solomon Islands
1
Palestine
1
North Korea
1
Djibouti
1
Mongolia
1
Qatar
1
Bulgaria
1
Lithuania
1
Kazakhstan
1
Gabon
1
Uruguay
1
Turkmenistan
1
Belgium
1
Maldives
1
Tunisia
1
Azerbaijan
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
1714
Clinical Guidelines
287
Public Health
144
Women & Child Health
120
Key Resources
67
Capacity Building
64
Pharmacy & Technologies
35
Annual Report MEDBOX
3
Toolboxes
TB
837
HIV
553
AMR
130
COVID-19
127
Mental Health
91
NTDs
77
Caregiver
75
Pharmacy
67
NCDs
52
Ebola
49
Refugee
46
Conflict
42
Global Health Education
40
Disability
37
Rapid Response
32
Polio
25
Health Financing Toolbox
25
Natural Hazards
18
Planetary Health
16
Cholera
9
Social Ethics
8
Zika
6
Specific Hazards
5
South Sudan
1
Health Financing
1
Therapeutics for Ebola virus disease
recommended
The WHO Ebola Virus Disease (EVD) Clinical management: living guidance contains the Organization’s most up-to-date recommendations for the clinical management of people with EVD. Providing guidance that is comprehensive and holistic for the optimal care of patients with EVD throughout their il...
Getting on track to end AIDS as a public health threat by 2030. This new Road Map charts a way forward for country-level actions to achieve an ambitious set of HIV prevention targets by 2025. Those targets emerged from the 2021 Political Declaration on HIV and AIDS, which the United Nations General ...
This collection of case studies on risk communication and community engagement (RCCE) from 18 different country/area level public health partners in the WHO European Region provides evidence of numerous results achieved and lessons learned since the start of the COVID-19 pandemic. RCCE has not...
The world faces grave consequences from the lack of available mental health services and treatment. Mental illness impacts every country, culture and community, with the World Health Organization (WHO) stating that 10% of the global burden of diseas...
Conflict
In early October, Ukrainian forces continued recapturing areas of southern and eastern oblasts, notably Lyman (Donetsk oblast). The liberation of thousands of square kilometres resulted in the grim discovery of two new mass graves in Lyman and Sviatohirsk (containing of 120 civilian bodi...
Not long ago, on the occasion of the 100th anniversary of the discovery of Chagas disease, several campaigns denounced the scant progress has been made in diffrent spheres- medical, scientific and politcal- but major challanges still remain. This is an appropriate time to celebrate what has been ach...
Schistosomiasis is widely recognized as a disease that is socially determined. An understanding of the social and behavioural factors linked to disease transmission and control should play a vital role in designing policies and strategies for schistosomiasis prevention and control. To this must be a...
Schistosomiasis is widely recognized as a disease that is socially determined. An
understanding of the social and behavioural factors linked to disease transmission and
control should play a vital role in designing policies and strategies for schistosomiasis
prevention and control. To this must b...
Frequently Asked Questions on Visceral Leishmaniasis
PLoS Negl Trop Dis 16(10): e0009774. Although the practice of communication is often called upon when intervening asn involgvingcommunties affected by NTD's, the disciplinary framewokr of healt communication research has been largely absent from NTD strategies. To illustrate how practices conceptual...
This fourth WHO report on neglected tropical diseases (NTDs) reviews the progress made towards achieving the Roadmap targets for 2020, noting the remaining challenges, then looks beyond 2020 to evaluate the changing global health and development landscape, considering the implications of integrating...
Obesity in all age groups, including children and adolescents, is a public health challenge across all settings. Obesity is now classified as a complex multifactorial chronic disease and not just a risk factor for other noncommunicable diseases and comorbidities. Recognizing the significance of prim...
Cystic echinococcosis (CE) is a well-known neglected parasitic disease. However, evidence supporting the four current treatment modalities is inadequate, and treatment options remain controversial. ...
This policy brief describes key HIV viral load thresholds and the available viral load testing approaches for monitoring how well antiretroviral therapy is working for people living with HIV. It provides clarification for and elaborates upon the current tr... monitoring algorithm from the Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach.
This information can help people living with HIV to live healthy lives, ensure that HIV is not transmitted to other people and support policy-makers in determining the optimal allocation of resources for viral load testing and communicating the results.
Cholera is a major health risk in many parts of the world, affecting millions of people every year. Since mid-2021, the world has been facing an acute upsurge of the 7th cholera pandemic, which is characterized by the number, size and concurrence of multiple outbreaks, the spread to areas that had b...
WHO/Europe has launched a new guide, providing support to countries on how to apply behavioural and cultural insights (BCI) for health. It presents a simple step-wise approach, complemented by a rich collection of detailed considerations, tools and exercises. The guide is the first of its kind, spec...
The response to a cholera outbreak must focus on limiting mortality and reducing the spread of the disease. It should be comprehensive and multisectoral, including epidemiology, case management, water, sanitation and hygiene, logistics, community engagement and risk communication. All efforts must b...
Heart failure with a reduced ejection fraction (HFrEF) is a condition frequently encountered by healthcare professionals and, in order to achieve the best outcomes for patients, needs to be managed optimally. This guideline document is based on the European Society of Cardiology Guidelines for the <... of acute and chronic heart failure published in 2016, and summarises what is considered the best current management of patients with the condition. It provides information on the definition, diagnosis and epidemiology of HFrEF in the African context. The best evidence-based treatments for HFrEF are discussed, including established therapies (beta-blockers, ACE-i/ARBs, mineralocorticoid receptor antagonists (MRAs), diuretics) that form the cornerstone of heart failure management as well as therapies that have only recently entered clinical use (angiotensin receptor-neprilysin inhibitor (ARNI), sodium/glucose cotransporter-2 (SGLT2) inhibitors). Guidance is offered in terms of more invasive therapies (revascularisation, implantable cardioverter defibrillators (ICDs) and cardiac resynchronisation therapy (CRT) by implantation of a biventricular pacemaker with (CRT-D) or without (CRT-P) an ICD, left ventricular assist device (LVAD) use and heart transplantation) in order to ensure efficient use of these expensive treatment modalities in a resourcelimited environment. Furthermore, additional therapies (digoxin, hydralazine and nitrates, ivabradine, iron supplementation) are discussed and advice is provided on general preventive strategies (vaccinations). Sections to discuss conditions that are particularly prevalent in sub-Saharan Africa (HIV-associated cardiomyopathy (CMO), peripartum CMO, rheumatic heart disease, atrial fibrillation) have been added to further improve clinical care for these commonly encountered disease processes.
Background: Atherosclerotic cardiovascular diseases (ASCVD) including myocardial infarction, stroke and peripheral arterial disease continue to be major causes of premature death, disability and healthcare expenditure globally. Preventing the accumulation of cholesterol-containing atherogenic lipopr...
In 2012, all Member States of the World Health Organization (WHO) endorsed a historical target to reduce premature mortality from noncommunicable diseases
(NCD). This commitment was echoed in 2015 by the United Nations Sustainable Development Goals, which included a target to reduce premature morta...
